Reshma Kewalramani
Amgen (United States)(US)
Publications by Year
Research Areas
Dialysis and Renal Disease Management, Erythropoietin and Anemia Treatment, Chronic Kidney Disease and Diabetes, Parathyroid Disorders and Treatments, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease(2009)2,057 cited
- → Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism(2017)299 cited
- → Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism(2017)151 cited
- → Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference(2017)145 cited
- → Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD(2011)142 cited
- → Pharmacoepidemiology of Anemia in Kidney Transplant Recipients(2004)136 cited
- → CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo(2005)92 cited
- → Kidney Function, Albuminuria, and All-Cause Mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study(2010)83 cited
- → Albuminuria and Racial Disparities in the Risk for ESRD(2011)79 cited
- → Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)(2009)66 cited